Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

This study has been completed.
Information provided by (Responsible Party):
Centocor, Inc. Identifier:
First received: December 22, 2005
Last updated: November 3, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 1996
  Primary Completion Date: October 1996 (Final data collection date for primary outcome measure)